0000000000861454

AUTHOR

B. Maalem

showing 1 related works from this author

Impact pronostique de l’HbA1c et de la glycémie plasmatique (Gp) à la phase aiguë d’un infarctus du myocarde sur la mortalité à un an chez des patien…

2020

International audience; Background: The usefulness of the combined assessment of HbA1c and plasma glucose (PG) in acute myocardial infarction (AMI) in non-diabetic patients remains unclear.Purpose: In a large observational study, we aimed to identify the prognostic values of these biomarkers regarding one-year all-cause mortality in non-diabetic patients after AMI.Methods: From the "obseRvatoire des Infarctus de Côte d'Or" (RICO) survey database, we included all consecutive non-diabetic patients with AMI (n=6617) from May 2001 to December 2016. Exclusion criteria were: admission known or unknown diabetes, in-hospital death. The primary endpoint was all-cause one-year mortality. The secondar…

Gynecologymedicine.medical_specialtyHbA1cbusiness.industryGlycemic stress[SDV]Life Sciences [q-bio]Non-diabetic030204 cardiovascular system & hematologyMyocardial infraction3. Good health[SDV] Life Sciences [q-bio]One year mortality03 medical and health sciencesOne-year mortality0302 clinical medicineMedicineCardiology and Cardiovascular MedicinebusinessNon diabetic
researchProduct